Eli Lilly and Company

LLYC.VI·Vienna·Healthcare
Compare
1,275.20+3.60 (+0.28%)today
As of Nov 5, 1:00 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,271.60
Open1,280.40
Day range1,273.001,280.40
52-week range730.001,280.40
Off day high−0.41%
Off 52-week high−0.41%
Volume0.00
Avg. volume (3M)20.00
Market cap1.14T
EPS (TTM)26.52
Forward P/E—
P/E ratio (TTM)48.08
Dividend yield0.49% (6.17)
Beta (5Y)0.39
Shares outstanding890.75M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin31.90%

Against its peers

Compare in full ›
LLYC.VI 0QCV.IL BMY BIIB 0QYQ.IL AZN
Market cap 1.14T 536.09B 131.21B 37.61B 217.96B 293.14B
P/E (TTM) 48.1 61.3 14.2 110.2 40.2 26.7
Forward P/E — — 9.6 15.6 — 16.7
Price/book 31.7 40.9 5.6 2.0 10.3 5.7
Dividend yield 0.49% 4.05% 3.93% — 3.81% 1.69%
1-year change +56.27% +30.72% +37.66% +62.35% +40.64% +12.81%
Today +0.28% +4.93% +4.02% +2.22% +1.70% +2.79%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Eli Lilly's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
AbbVie Inc.0QCV.IL · Drug Manufacturers - General 536.09B 298.00 +4.93%
Bristol-Myers Squibb CompanyBMY · Drug Manufacturers - General 131.21B 64.19 +4.02%
Biogen Inc.BIIB · Drug Manufacturers - General 37.61B 254.46 +2.22%
Gilead Sciences, Inc.0QYQ.IL · Drug Manufacturers - General 217.96B 174.93 +1.70%
AstraZeneca PLCAZN · Drug Manufacturers - General 293.14B 189.01 +2.79%
Novo Nordisk A/SNOV.DE · Drug Manufacturers - General 162.55B 36.87 −2.85%
Chugai Pharmaceutical Co., Ltd.CUP.F · Drug Manufacturers - General 65.86B 40.02 +4.33%
Orion OyjOFK.F · Drug Manufacturers - General 14.28B 101.70 +2.99%

Other companies in Drug Manufacturers - General, closest in size first.

Company Mkt cap Price Today
Novo Nordisk A/SNOVOBC.XC · Bagsvaerd, Denmark 1.26T 284.00 0.00%
Ono Pharmaceutical Co., Ltd.4528.T · Osaka, Japan 1.17T 2,489.00 +4.62%
Gilead Sciences, Inc.GILD34.SA · Foster City, CA 1.19T 79.85 +3.33%
Pfizer Inc.PFIZ34.SA · New York, NY 953.24B 41.81 +1.38%
Bayer AktiengesellschaftBAYNN.MX · Leverkusen, Germany 936.33B 953.08 0.00%
Amgen Inc.AMGN34.SA · Thousand Oaks, CA 1.42T 93.78 +3.49%
JOHNSON & JOHNSON CDR (CAD HEDGJNJ.NE · New Brunswick, NJ 915.54B 35.27 +4.32%
Biogen Inc.BIIB.MX · Cambridge, MA 693.22B 4,689.60 0.00%

The stocks whose daily moves over the past year went most closely with Eli Lilly's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Eli Lilly and CompanyLLY.DE · Correlation 0.97 1.14T 1,276.60 +0.20%
Eli Lilly and CompanyLLY.F · Correlation 0.89 1.14T 1,275.80 +0.84%
Eli Lilly and CompanyLLY.SW · Correlation 0.57 1.05T 1,180.00 +23.56%

What visitors to Eli Lilly's page also look at.

Company Mkt cap Price Today
Eli Lilly and CompanyLLY.DE 1.14T 1,276.60 +0.20%
Eli Lilly and CompanyLLY.F 1.14T 1,275.80 +0.84%
ADOBE SYSTEMS INCADBE.VI 87.39B 224.55 +1.88%
LILLY ELILLY.SW 1.05T 1,180.00 +23.56%
Walmart Inc.WMT.F 921.07B 115.74 −0.07%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All LLYC.VI news ›
Sports Business Journal·Positive

Excel Sports Management adds key accounts with Deloitte, Eli Lilly

Sports Business Journal Excel Sports Management adds key accounts with Deloitte, Eli Lilly Acclamation should be extended to Excel Sports Management for noteworthy agency of record wins in two recent RFPs. Industry sources tell us E

LLY
Seeking Alpha·Positive

Eli Lilly: Higher Volume, Lower Realized Prices

Pharmaceutical company Eli Lilly and Company (LLY) reported volume growth of 53% last quarter against a 15% decline in realized prices. Revenue rose 39%. Gross margin went up year-over-year, too. That combination is unusual Best Stocks Now…

LLYNVOPFE
Trefis·Negative

Is Eli Lilly Stock Increasing Your Market Risk?

Eli Lilly Stock Has Barely Followed The Market No, not over the past year. Between October 31, 2025, and November 3, 2026, the S&P 500 lost 0.606% on the average day it fell, while a $10,000 holding of Lilly stock gained about $15.70. On…

LLYNVOPFE
Trefis·

The One Thing To Settle Before Buying Eli Lilly Stock

Eli Lilly (LLY) is selling far more of two drugs, Mounjaro and Zepbound, than it did a year ago. The price the company collects in the U.S., however, is falling. For anyone who owns the stock, the depth of that decline is not settled. This…

LLYNVOPFE
Seeking Alpha·Negative

Eli Lilly: Priced For Acceleration, Reporting Deceleration

Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price erosion deepened. Read more on LLY stock here. - Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price…

LLYNVOPFE

From the 4Search news index, newest first.

In the news

361mentions in 30 days
361with it in the headline
Positivesentiment

Mentioned with

Eli Lilly and Company307Novo Nordisk291Pfizer236Colonel Eli Lilly173Johnson & Johnson122Mckesson102Eli Lilly and Company Eli Lilly and Company100Merck & Co., Inc.77

People in the coverage

Mounjaro291Foundayo282Zepbound248Verzenio219Kisunla218Danessa Lincoln209

Themes

Lly300Nvo172Usmf-Health-Care172Eli Lilly and Company161Healthcare15153245710120Mrk111Pharmaceuticals104

Most coverage from

  1. marketscreener.com34
  2. fool.com28
  3. seekingalpha.com28
  4. 247wallst.com22
  5. defenseworld.net22

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance